Patent · US Active

Anti-Axl antagonistic antibodies

US10208121B2 · kind B2 · utility

1Cited by
3References
26Claims
0Family size

Assignees

Inventors

Key dates

Filing dateDec 18, 2015
Grant dateFeb 19, 2019
Priority date
Expiry dateFeb 23, 2036

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/71
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Described are antibodies that specifically bind to the Axl protein and inhibit the interaction between Axl and the Axl-ligand, Gas6. Also disclosed are methods for the production and use of the anti-Axl antibodies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.